Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara W Chew

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
JCI Insight|December 20, 2024
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
The Journal of Infectious Diseases|July 19, 2024
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical TrialKara W Chew, Babafemi O Taiwo, Carlee Moser, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 26, 2024
Evaluation of GeneXpert and advanced biological laboratories UltraGene HCV diagnostic detection and performance against Roche real time PCR in MyanmarPedro Pisa, Constance Wose Kinge, Charles Chasela, et al.
Iscience|March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodiesRachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
The Journal of Infectious Diseases|July 22, 2024
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody FeedbackNathaniel Bloom, Sydney I Ramirez, Hallie Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 TrialNikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 14, 2022
Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co-infected patients in UkraineSergie Antoniak, Charles S Chasela, Morgan Julie Freiman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Journal of Viral Hepatitis|September 16, 2020
Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in MyanmarYin Min Thaung, Charles S Chasela, Kara W Chew, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
JCI Insight|December 20, 2024
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
The Journal of Infectious Diseases|July 19, 2024
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical TrialKara W Chew, Babafemi O Taiwo, Carlee Moser, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Early antiviral CD4 and CD8 T cell responses and antibodies are associated with upper respiratory tract clearance of SARS-CoV-2Sydney I Ramirez, Paul G Lopez, Farhoud Faraji, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 26, 2024
Evaluation of GeneXpert and advanced biological laboratories UltraGene HCV diagnostic detection and performance against Roche real time PCR in MyanmarPedro Pisa, Constance Wose Kinge, Charles Chasela, et al.
Iscience|March 24, 2025
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodiesRachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
The Journal of Infectious Diseases|July 22, 2024
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody FeedbackNathaniel Bloom, Sydney I Ramirez, Hallie Cohn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 6, 2023
One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019: A Randomized Controlled Phase 2 TrialNikolaus Jilg, Kara W Chew, Mark J Giganti, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 14, 2022
Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co-infected patients in UkraineSergie Antoniak, Charles S Chasela, Morgan Julie Freiman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2025
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled TrialAnne F Luetkemeyer, Kara W Chew, Stuart Lacey, et al.
Journal of Viral Hepatitis|September 16, 2020
Treatment outcomes and costs of a simplified antiviral treatment strategy for hepatitis C among monoinfected and HIV and/or hepatitis B virus-co-infected patients in MyanmarYin Min Thaung, Charles S Chasela, Kara W Chew, et al.
Pageof 10